speb/financial-data huggingface dataset:
RXO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -56000000.00
RXO income_statement (annual, 2024-12-31) — Total Unusual Items: -86000000.00
RXO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -86000000.00
RXO balance_sheet (annual, 2024-12-31) — Working Capital: 274000000.00
RXO income_statement (quarterly, 2025-03-31) — +Operating Expense: 210000000.00
RXO income_statement (quarterly, 2025-03-31) — +Total Revenue: 1433000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 498000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1150000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -333000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1908000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -11000000.00
RXO cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 4000000.00
RXO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 168023000.00
RXO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.18
RXO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 35000000.00
RXO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -15000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 281000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 16000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 16000000.00
RXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 7000000.00
RXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -25000000.00
RXO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -2000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -56000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -15000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -10000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Payable: -56000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -71000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 76000000.00
RXO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -5000000.00
RXO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 76000000.00
RXO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -20000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Common Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1587000000.00
RXO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1233000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 358000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1255000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 80000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Debt: 17000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 97000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 964000000.00
RXO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -11000000.00
RXO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -11000000.00
RXO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 32000000.00
RXO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 32000000.00
RXO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 168023000.00
RXO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.18
RXO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — EBIT: -30000000.00
RXO income_statement (quarterly, 2025-03-31) — EBITDA: 2000000.00
RXO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1000000.00
RXO cash_flow (quarterly, 2025-03-31) — End Cash Position: 16000000.00
RXO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 7000000.00
RXO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -17000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -8000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Goodwill: 1124000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 1608000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1161000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 732000000.00
RXO income_statement (quarterly, 2025-03-31) — Gross Profit: 200000000.00
RXO cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 1000000.00
RXO income_statement (quarterly, 2025-03-31) — Interest Expense: 9000000.00
RXO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 9000000.00
RXO cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 2000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1991000000.00
RXO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -25000000.00
RXO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 300000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 201000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 387000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 588000000.00
RXO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 300000000.00
RXO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -265000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -10000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Net Debt: 388000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -31000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -31000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Interest Income: -9000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 35000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 35000000.00
RXO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -9000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -28000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Net PPE: 399000000.00
RXO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -15000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -21000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 77000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 77000000.00
RXO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 22000000.00
RXO income_statement (quarterly, 2025-03-31) — Normalized Income: -14840000.00
RXO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -2000000.00
RXO income_statement (quarterly, 2025-03-31) — Operating Income: -10000000.00
RXO income_statement (quarterly, 2025-03-31) — Operating Revenue: 1433000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 163912000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 89000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 17000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 11000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -8000000.00
RXO income_statement (quarterly, 2025-03-31) — Other Income Expense: -20000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 484000000.00
RXO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 2000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 42000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 88000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Other Properties: 732000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Payables: 498000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 856000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
RXO income_statement (quarterly, 2025-03-31) — Pretax Income: -39000000.00
RXO cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -10000000.00
RXO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -15000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Receivables: 1150000000.00
RXO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1233000000.00
RXO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 32000000.00
RXO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -265000000.00
RXO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 20000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -315000000.00
RXO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 210000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Share Issued: 163912000.00
RXO income_statement (quarterly, 2025-03-31) — Special Income Charges: -20000000.00
RXO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 7000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1587000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -21000000.00
RXO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -3840000.00
RXO income_statement (quarterly, 2025-03-31) — Tax Provision: -8000000.00
RXO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.19
RXO balance_sheet (quarterly, 2025-03-31) — Total Assets: 3304000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1974000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Debt: 685000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1587000000.00
RXO income_statement (quarterly, 2025-03-31) — Total Expenses: 1443000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1717000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2049000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 753000000.00
RXO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -30000000.00
RXO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -20000000.00
RXO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -20000000.00
RXO balance_sheet (quarterly, 2025-03-31) — Working Capital: 291000000.00
RXO income_statement (quarterly, 2025-06-30) — +Operating Expense: 214000000.00
RXO income_statement (quarterly, 2025-06-30) — +Total Revenue: 1419000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 461000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1065000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -351000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1915000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: -16000000.00
RXO cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 0.00
RXO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 168525000.00
RXO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.05
RXO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 16000000.00
RXO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -14000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 276000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 18000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 18000000.00
RXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3000000.00
RXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -18000000.00
RXO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 23000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -37000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: -56000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 3000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Payable: -37000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -93000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 83000000.00
RXO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -7000000.00
RXO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 83000000.00
RXO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 2000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Common Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1588000000.00
RXO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1195000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 315000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1184000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 75000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Debt: 16000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 91000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 880000000.00
RXO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -2000000.00
RXO cash_flow (quarterly, 2025-06-30) — Deferred Tax: -2000000.00
RXO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 30000000.00
RXO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 30000000.00
RXO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 168525000.00
RXO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.05
RXO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — EBIT: -2000000.00
RXO income_statement (quarterly, 2025-06-30) — EBITDA: 28000000.00
RXO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 1000000.00
RXO cash_flow (quarterly, 2025-06-30) — End Cash Position: 19000000.00
RXO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3000000.00
RXO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 9000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -5000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Goodwill: 1125000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 1599000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 1081000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 738000000.00
RXO income_statement (quarterly, 2025-06-30) — Gross Profit: 224000000.00
RXO cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 3000000.00
RXO income_statement (quarterly, 2025-06-30) — Interest Expense: 8000000.00
RXO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 8000000.00
RXO cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 14000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1991000000.00
RXO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -18000000.00
RXO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: -39000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 201000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 387000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 588000000.00
RXO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: 264000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 0.00
RXO balance_sheet (quarterly, 2025-06-30) — Net Debt: 385000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -9000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -9000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Interest Income: -8000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -36000000.00
RXO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -8000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -1000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Net PPE: 387000000.00
RXO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -13000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -11000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 75000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 75000000.00
RXO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 38000000.00
RXO income_statement (quarterly, 2025-06-30) — Normalized Income: -450000.00
RXO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 23000000.00
RXO income_statement (quarterly, 2025-06-30) — Operating Income: 10000000.00
RXO income_statement (quarterly, 2025-06-30) — Operating Revenue: 1419000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 163970000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 101000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 16000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 13000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -5000000.00
RXO income_statement (quarterly, 2025-06-30) — Other Income Expense: -12000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 474000000.00
RXO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 4000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 31000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 70000000.00
RXO income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -2000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Other Properties: 738000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Payables: 461000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 776000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
RXO income_statement (quarterly, 2025-06-30) — Pretax Income: -10000000.00
RXO cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
RXO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -14000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Receivables: 1065000000.00
RXO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1195000000.00
RXO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 30000000.00
RXO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: 37000000.00
RXO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 10000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -324000000.00
RXO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 214000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Share Issued: 163970000.00
RXO income_statement (quarterly, 2025-06-30) — Special Income Charges: -10000000.00
RXO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 7000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1588000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -11000000.00
RXO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -1450000.00
RXO income_statement (quarterly, 2025-06-30) — Tax Provision: -1000000.00
RXO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.15
RXO balance_sheet (quarterly, 2025-06-30) — Total Assets: 3201000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1975000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Debt: 679000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1588000000.00
RXO income_statement (quarterly, 2025-06-30) — Total Expenses: 1409000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1613000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2017000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 733000000.00
RXO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 0.00
RXO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -10000000.00
RXO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -10000000.00
RXO balance_sheet (quarterly, 2025-06-30) — Working Capital: 304000000.00
RXO income_statement (quarterly, 2025-09-30) — +Operating Expense: 208000000.00
RXO income_statement (quarterly, 2025-09-30) — +Total Revenue: 1421000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 481000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1104000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -365000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1922000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -15000000.00
RXO cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: -1000000.00
RXO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 168578000.00
RXO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.08
RXO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 19000000.00
RXO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -14000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 279000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 25000000.00
RXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -3000000.00
RXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -13000000.00
RXO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 23000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 19000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -2000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 27000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Payable: 19000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 17000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -39000000.00
RXO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 5000000.00
RXO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -39000000.00
RXO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1580000000.00
RXO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1211000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 321000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Assets: 1201000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 77000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Debt: 16000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 93000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 907000000.00
RXO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -2000000.00
RXO cash_flow (quarterly, 2025-09-30) — Deferred Tax: -2000000.00
RXO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 26000000.00
RXO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 26000000.00
RXO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 168578000.00
RXO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.08
RXO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — EBIT: -6000000.00
RXO income_statement (quarterly, 2025-09-30) — EBITDA: 20000000.00
RXO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 0.00
RXO cash_flow (quarterly, 2025-09-30) — End Cash Position: 26000000.00
RXO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -3000000.00
RXO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 9000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -6000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Goodwill: 1123000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1586000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1119000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 756000000.00
RXO income_statement (quarterly, 2025-09-30) — Gross Profit: 210000000.00
RXO cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 2000000.00
RXO income_statement (quarterly, 2025-09-30) — Interest Expense: 9000000.00
RXO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 9000000.00
RXO cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1983000000.00
RXO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -13000000.00
RXO cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 210000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 202000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 387000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 589000000.00
RXO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: 0.00
RXO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
RXO balance_sheet (quarterly, 2025-09-30) — Net Debt: 378000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -14000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -14000000.00
RXO income_statement (quarterly, 2025-09-30) — Net Interest Income: -9000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -1000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
RXO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -9000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -2000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 1000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Net PPE: 391000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -14000000.00
RXO cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -1000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -6000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 54000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 54000000.00
RXO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 29000000.00
RXO income_statement (quarterly, 2025-09-30) — Normalized Income: -5828000.00
RXO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 23000000.00
RXO income_statement (quarterly, 2025-09-30) — Operating Income: 2000000.00
RXO income_statement (quarterly, 2025-09-30) — Operating Revenue: 1421000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 164103000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 72000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 16000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 12000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -6000000.00
RXO income_statement (quarterly, 2025-09-30) — Other Income Expense: -8000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 463000000.00
RXO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 23000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 71000000.00
RXO income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 1000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Other Properties: 756000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Payables: 481000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 802000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
RXO income_statement (quarterly, 2025-09-30) — Pretax Income: -15000000.00
RXO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
RXO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -14000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Receivables: 1104000000.00
RXO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1211000000.00
RXO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 26000000.00
RXO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -211000000.00
RXO income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 9000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -338000000.00
RXO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
RXO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 208000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Share Issued: 164103000.00
RXO cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 210000000.00
RXO cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -211000000.00
RXO income_statement (quarterly, 2025-09-30) — Special Income Charges: -9000000.00
RXO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 8000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1580000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -6000000.00
RXO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -828000.00
RXO income_statement (quarterly, 2025-09-30) — Tax Provision: -1000000.00
RXO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.09
RXO balance_sheet (quarterly, 2025-09-30) — Total Assets: 3201000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1967000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Debt: 682000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1580000000.00
RXO income_statement (quarterly, 2025-09-30) — Total Expenses: 1419000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1621000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2000000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 714000000.00
RXO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -7000000.00
RXO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -9000000.00
RXO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -9000000.00
RXO balance_sheet (quarterly, 2025-09-30) — Working Capital: 294000000.00
RXO income_statement (annual, 2025-12-31) — +Operating Expense: 832000000.00
RXO income_statement (quarterly, 2025-12-31) — +Operating Expense: 200000000.00
RXO income_statement (annual, 2025-12-31) — +Total Revenue: 5742000000.00
RXO income_statement (quarterly, 2025-12-31) — +Total Revenue: 1469000000.00
RXO balance_sheet (annual, 2025-12-31) — Accounts Payable: 539000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 539000000.00
RXO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 1226000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 1226000000.00
RXO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -381000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -381000000.00
RXO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1929000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1929000000.00
RXO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -16000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -16000000.00
RXO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 47000000.00
RXO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 47000000.00
RXO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 16000000.00
RXO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 13000000.00
RXO income_statement (annual, 2025-12-31) — Basic Average Shares: 168462000.00
RXO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 168715000.00
RXO income_statement (annual, 2025-12-31) — Basic EPS: -0.59
RXO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.27
RXO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 35000000.00
RXO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26000000.00
RXO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 57000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 57000000.00
RXO cash_flow (annual, 2025-12-31) — Capital Expenditure: -59000000.00
RXO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -16000000.00
RXO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 266000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 266000000.00
RXO balance_sheet (annual, 2025-12-31) — Capital Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000000.00
RXO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 17000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 17000000.00
RXO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 17000000.00
RXO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1000000.00
RXO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
RXO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -71000000.00
RXO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15000000.00
RXO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 51000000.00
RXO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Account Payable: -16000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 58000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 75000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 19000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -1000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Payable: -16000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Payable: 58000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -14000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 133000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Receivables: -5000000.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Receivables: -125000000.00
RXO cash_flow (annual, 2025-12-31) — Change In Working Capital: 0.00
RXO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 7000000.00
RXO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5000000.00
RXO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -125000000.00
RXO cash_flow (annual, 2025-12-31) — Changes In Cash: -19000000.00
RXO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -8000000.00
RXO balance_sheet (annual, 2025-12-31) — Common Stock: 2000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000000.00
RXO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1541000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1541000000.00
RXO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
RXO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
RXO cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
RXO income_statement (annual, 2025-12-31) — Cost Of Revenue: 4917000000.00
RXO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1278000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 397000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 397000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Assets: 1317000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Assets: 1317000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 75000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 75000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Debt: 17000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Debt: 17000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 92000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 92000000.00
RXO balance_sheet (annual, 2025-12-31) — Current Liabilities: 1038000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1038000000.00
RXO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -21000000.00
RXO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -6000000.00
RXO cash_flow (annual, 2025-12-31) — Deferred Tax: -21000000.00
RXO cash_flow (quarterly, 2025-12-31) — Deferred Tax: -6000000.00
RXO cash_flow (annual, 2025-12-31) — Depreciation: 69000000.00
RXO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 116000000.00
RXO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 28000000.00
RXO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 116000000.00
RXO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 28000000.00
RXO income_statement (annual, 2025-12-31) — Diluted Average Shares: 168462000.00
RXO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 168715000.00
RXO income_statement (annual, 2025-12-31) — Diluted EPS: -0.59
RXO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.27
RXO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -46000000.00
RXO income_statement (annual, 2025-12-31) — EBIT: -80000000.00
RXO income_statement (quarterly, 2025-12-31) — EBIT: -42000000.00
RXO income_statement (annual, 2025-12-31) — EBITDA: 36000000.00
RXO income_statement (quarterly, 2025-12-31) — EBITDA: -14000000.00
RXO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 2000000.00
RXO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 0.00
RXO cash_flow (annual, 2025-12-31) — End Cash Position: 18000000.00
RXO cash_flow (quarterly, 2025-12-31) — End Cash Position: 18000000.00
RXO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 1000000.00
RXO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
RXO cash_flow (annual, 2025-12-31) — Free Cash Flow: -8000000.00
RXO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9000000.00
RXO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -6000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -6000000.00
RXO balance_sheet (annual, 2025-12-31) — Goodwill: 1111000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Goodwill: 1111000000.00
RXO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 1564000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 1564000000.00
RXO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 1242000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 1242000000.00
RXO balance_sheet (annual, 2025-12-31) — Gross PPE: 753000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 753000000.00
RXO income_statement (annual, 2025-12-31) — Gross Profit: 825000000.00
RXO income_statement (quarterly, 2025-12-31) — Gross Profit: 191000000.00
RXO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 12000000.00
RXO cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 7000000.00
RXO cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1000000.00
RXO income_statement (annual, 2025-12-31) — Interest Expense: 35000000.00
RXO income_statement (quarterly, 2025-12-31) — Interest Expense: 9000000.00
RXO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 35000000.00
RXO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 9000000.00
RXO cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 32000000.00
RXO cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 15000000.00
RXO balance_sheet (annual, 2025-12-31) — Invested Capital: 1945000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1945000000.00
RXO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -71000000.00
RXO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -15000000.00
RXO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
RXO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
RXO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 566000000.00
RXO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 95000000.00
RXO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 191000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 191000000.00
RXO balance_sheet (annual, 2025-12-31) — Long Term Debt: 387000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 387000000.00
RXO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 578000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 578000000.00
RXO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 566000000.00
RXO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -535000000.00
RXO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -534000000.00
RXO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 435000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 435000000.00
RXO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -10000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
RXO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
RXO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
RXO balance_sheet (annual, 2025-12-31) — Net Debt: 387000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Net Debt: 387000000.00
RXO income_statement (annual, 2025-12-31) — Net Income: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -46000000.00
RXO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -100000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -100000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -46000000.00
RXO income_statement (annual, 2025-12-31) — Net Interest Income: -35000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Interest Income: -9000000.00
RXO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 31000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -1000000.00
RXO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 31000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 32000000.00
RXO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -35000000.00
RXO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -9000000.00
RXO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -30000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1000000.00
RXO cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -4000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
RXO balance_sheet (annual, 2025-12-31) — Net PPE: 372000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Net PPE: 372000000.00
RXO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -57000000.00
RXO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -15000000.00
RXO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -23000000.00
RXO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -23000000.00